6-bromo-2-oxo-1,2,3,4-tetrahydroquinoline-4-carboxylic acid – (264276-41-7)

790702-57-7, NGI-1, ML414, 5-(dimethylsulfamoyl)-N-(5-methyl-1, 3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide, 5-(N, N-Dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide, MLS002248299, 5-(dimethylsulfamoyl)-N-(5-methyl-1, 3-thiazol-2-yl)-2-pyrrolidin-1-ylbenzamide, SMR001315774, NGI 1, KSC-367-096-1, NGI1, KUC113535N-NLG, CHEMBL1720448, SCHEMBL20598184, cid_2519269, ML414 NGI-1, NGI-1(ML414), BDBM114446, DTXSID601322912, HMS3081P23, KUC113535N, N-linked Glycosylation Inhibitor-1, NGI-1 (ML414), BCP29639, EX-A2753, NGI-1 (ML414)?, s8750, ZB1632, AKOS017066633, KUC113535N-02, NCGC00351072-01, AC-35603, AS-73727, BN164083, KSC-432-019-1, HY-117383, CS-0065599, C76532, EN300-182616, BRD-K40795977-001-04-3, BRD-K40795977-001-07-6, Z29324102, NGI1 NGI 1 ML414 ML 414 ML-414, 5-(dimethylsulfamoyl)-N-(5-methyl-2-thiazolyl)-2-(1-pyrrolidinyl)benzamide, 5-(dimethylsulfamoyl)-N-(5-methylthiazol-2-yl)-2-pyrrolidino-benzamide, 5-(dimethylsulfamoyl)-~{N}-(5-methyl-1, 3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide, 5-(dimethylsulfamoyl)-N-(5-methyl-1, 3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benz amide, 5-(dimethylsulfamoyl)-N-(5-methyl-1, 3-thiazol-2-yl)-2-pyrrolidin-1-yl-benzamide, 839-712-9, ZXT